Tradestie Institutional Equity Comparison Engine
ABVE vs MBIO โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
MBIO Overall Edge
MBIO Captures Institutional Edge (2โ1 Pillars ยท 6โ2 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Mustang Bio, Inc. (MBIO) driven by superior Growth & Margin, Momentum & Technical while ABVE counters with relative strength in Options & Structure. Fundamentally, ABVE trades at N/M Forward P/E with -23.2% operating margin (-45.0% YoY revenue) versus MBIO at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, ABVE sits in UNCLASSIFIED (8th %ile IV; Dealer Gamma Walls on Pro) against MBIO sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
ABVE N/M vs MBIO N/M Fwd P/E
Growth & Margin Winner
MBIO
Op Margin -23.2% vs 0.0% ยท YoY -45.0% vs +0.0%
Momentum & Technical Winner
MBIO
1Y -90.2% vs -67.4% ยท 52W Pos 0% vs 4%
Options & Structure Winner
ABVE
UNCLASSIFIED (8th %ile IV) vs UNCLASSIFIED (N/A IV)
ABVE
NASDAQ
Above Food Ingredients Inc. Common Stock
Food And Kindred Products
$0.11
-80.57% 1D
Market Cap
$30.0M
1M Return
-79.18%
1Y Return
-90.17%
Forward P/E
N/M
Unified AI Score
39.8 / 100
SELL
Tech 40.0
Fund 47.0
Flow 57.0
Mom 40.0
MBIO
NASDAQ
Mustang Bio, Inc.
Pharmaceutical Preparations
$0.39
-6.34% 1D
Market Cap
$3.2M
1M Return
+4.86%
1Y Return
-67.38%
Forward P/E
N/M
Unified AI Score
42.9 / 100
HOLD
Tech 40.0
Fund 49.0
Flow 50.0
Mom 70.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
ABVE -90.17%
MBIO -67.38%
Spread: +57.93 pp (MBIO Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
ABVE TTM Op. Margin: -23.2%
MBIO TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ABVE vs MBIO. Trailing 12-month operating profitability (ABVE -23.2% vs MBIO 0.0%) and valuation multiples (ABVE N/M vs MBIO N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | ABVE | MBIO | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $30.0M | $3.2M | Larger Scale | ABVE |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | -45.0% | +0.0% | Higher Growth | MBIO |
| Operating Margin (TTM) Profitability | -23.2% | 0.0% | Higher Margin | MBIO |
| Net Profit Margin Profitability | -23.4% | 0.0% | Higher Margin | MBIO |
| Return on Equity (ROE) Capital Efficiency | 0.0% | -43.1% | Higher ROE | ABVE |
| 52-Week Range Position Momentum | 0% ($0โ$7) | 4% ($0โ$1) | Stronger Trend | MBIO |
| Beta / 30D Volatility Risk Regime | 4.10ฮฒ ยท 310% Vol | 0.66ฮฒ ยท 86% Vol | Lower Realized Risk | MBIO |
| Unified Institutional Score Composite Signal | 39.8 / 100 (SELL) | 42.9 / 100 (HOLD) | Higher Composite | MBIO |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full ABVE vs MBIO Buy Guide
ABVE
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
8th %ile
IV Regime
Compressed (<25th %ile)
MBIO
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither ABVE nor MBIO registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.